Asthma is a disease of airway inflammation and hyperreactivity that is associated with a lymphocytic infiltrate in the bronchial submucosa. The interactions between infiltrating T lymphocytes with cellular and extraceUular matrix components of the airway and the consequences of these interactions have not been defined. We demonstrate the constitutive expression of CD44 on human airway smooth muscle (ASM) cells in culture as well as in human bronchial tissue transplanted into severe combined immunodeficient mice. In contrast, basal levels of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) expression are minimal but are induced on ASM by inflammatory mediators such as tumor necrosis factor ot (TNF-ct). Activated, but not resting T cells, adhere to cultured ASM; stimulation of the ASM with TNF-a enhanced this adhesion. Adhesion was partially blocked by monoclonal antibodies (mAb) specific for lymphocyte function-associated antigen 1 (LFA-1) and very late antigen 4 (VLA-4) on T cells and ICAM-1 and VCAM-1 on ASM cells. The observed integrin-independent adhesion was mediated by CD44/hyaluronate interactions as it was inhibited by anti-CD44 mAb 5F12 and by hyaluronidase. Furthermore, the adhesion of activated T lymphocytes induced DNA synthesis in growth-arrested ASM cells. Thus, the interaction between T cells and ASM may provide insight into the mechanisms that induce bronchial inflammation and possibly ASM cell hyperplasia seen in asthma.
A thma, a disease of reversible bronchial obstruction, is characterized by airway inflammation, epithelial damage, airway smooth muscle hyperplasia, and airway hyperresponsiveness. Although the eosinophil is one important effector cell in asthma, other inflammatory cells, particularly lymphocytes, are postulated to be critical in the initiation and perpetuation of airway inflammation. Bronchial biopsies from asthmatics exhibit increased numbers of lymphocytes in the submucosa (1) . In addition, an increase in the number of CD4 + T cells with a phenotype associated with T cell activation is found in bronchoalveolar lavage of asthma patients (2) (3) (4) . Activated T lymphocytes secrete a pattern of cytokines, including IL-4 and IL-5, characteristic of a Th2 phenotype (4) . In turn, these cytokines promote allergic type inflammatory responses such as eosinophil recruitment and isotype switching of B cells to production of IgE (5) .
In addition to secreting cytokines, T lymphocytes interact with other cell types by direct cell-cell contact. Recent attention has been directed toward the role of cell adhesion molecules in mediating airway inflammation (6) . Previous studies showed increased expression of the/$1 and/32 integrins very late antigen 4 (VLA-4) 1 and LFA-1, as well as of CD44, a receptor for hyaluronate (HA), on leukocytes recovered from the airways of patients with asthma (7, 8) . Furthermore, Wegner et al. (9) demonstrated that antibodies against intercellular adhesion molecule 1 (ICAM-1), a counter-receptor for LFA-1, decreased eosinophil infiltration, and attenuated bronchial hyperresponsiveness in a primate model of asthma. Adhesion molecules also mediate lymphocyte-endothelial cell interactions during the process of cell recruitment and homing. Although extravasation of lymphocytes from the circulation is a relatively well defined early step in establishing a local inflammatory response, the subsequent interactions of the infiltrating lymphocytes with other cell types in the bronchial submucosa or extracellular matrix, a step that may be important for sustaining the inflammatory response, remain largely unstudied.
Infiltrating lymphocytes are in close proximity with airway smooth muscle (ASM) cells, a cell type that is important in the pathogenesis of asthma. Interestingly, virtually nothing is known about the expression or function of adhesion molecules on ASM cells. We postulated that ASM, like vascular smooth muscle (VSM), expresses cell adhesion molecules that may be upregulated during inflammation and that lymphocyte-ASM interactions could have important consequences for both cell types. We therefore investigated the adhesion molecule repertoire of ASM, the potential for and mechanisms of lymphocyte-ASM interactions to occur, and the consequences of such cell-cell interactions.
Materials and Methods
mAbs. The following routine mAbs specific for human antigens were used: RR6. .ASM. Human ASM cells were isolated from the trachealis muscle of lung transplant donors and purified as described by Panettieri et al. (19) . These cells retain smooth muscle-specific actin expression as well as responsiveness to contractile agonists (19 Detection of DNA Synthesis. ASM cells were grown to subconfluence in 2-well slide culture fasks and serum-deprived for 48 h to establish quiescence. Resting or activated T cells were irradiated with 3,500 rad using a 137Cs source. T cells (5 x 105/well) were then added to the ASM and allowed to adhere for 42 h. During the final 24 h, cultures were incubated with 20 #M bromodeoxyuridine (BrdU; Sigma Chemical Co.). The slides were washed once with PBS, fixed in 70% ethanol for 30 min at room temperature, and allowed to air dry. Slides were exposed to 1 N HC1 for 5 min and washed with PBS. Primary antibody staining was performed with the hybridoma culture supernatant containing anti-BrdU mAb BU-1 (20) and detected with 10/~g/ml of FITCsheep anti-mouse IgG (Boehringer Mannheim, Indianapolis, IN). The cells were then counterstained with Evan's blue. Nuclei were visualized using a Leitz fluorescent microscope equipped with standard fluorescein and rhodamine filters. Random high power fields were chosen and photographed or the nuclei counted. The mitotic index was calculated as the ratio of BrdU positive nuclei/total nuclei _+ SEM from 50 high power fields for each condition from three separate experiments. Statistical significance was determined using one way analysis of variance. (22) . Briefly, segments of second to fifth generation human airway were dissected from surrounding adventitial tissue and transplanted subcutaneously into both flanks of SCID mice (23) obtained from a colony maintained in pathogen-free housing at the Wistar Institute. In this model, xenografts become revascularized within I wk of transplant and have a normal histologic appearance with little evidence of tissue rejection. A xenograft in one flank was injected with 50/~1 of endotoxin-free saline containing 2 mg/ml BSA (Sigma Chemical Co.) as a protein carrier plus 1% colloidal carbon to identify the injection site. The xenograft on the contralateral side was injected with 6,000 U of recombinant human TNF-ce (provided by Genentech Inc., S. San Francisco, CA) diluted in 50 #1 endotoxin-ffee saline containing 2 mg/ml BSA. 6 or 18 h after the injection the xenografts were removed and flash frozen at -70~ Frozen sections were stained as previously described (22) . Primary antibody was detected using the Vectastain ABC Elite Kit (Vector Laboratories, Inc., Burlingame, CA).
CD44 Transfectants.

Results
Constitutive and TNF-c~-inducible Expression of Adhesion Molecules on A S M Cells In Vitro. Analysis of immunoprecipi-
tates of extracts of [3SS]methionine-labeled ASM cells demonstrated constitutive expression of the "~90-kD hematopoietic form of CD44 that was not changed by treating the ASM with TNF-o~ (Fig. 1) . In contrast, ICAM-1 was expressed at low levels and VCAM-1 was not detectable on untreated ASM cells; both were markedly upregulated after treatment with TNF-a for 24 h. Binding ofradiolabeled anti-ICAM-1 antibody (data not shown) and immunofluorescent flow cytometry of single cell suspensions of ASM cells (Fig.  2) confirmed the cy.tokine-inducible expression of ICAM-1 and VCAM-1 on the cell surface. There was no expression of E-selectin on either resting or TNF-c~-stimulated ASM (data not shown).
TNF-o~ induction of ICAM-1 expression on ASM was dose and time dependent. Confluent ASM cells were stimulated with varying concentrations of TNF-oe for 24 h and analyzed by flow cytometry. TNF-oMnduced expression of ICAM-1 was detectable with 10 U/ml TNF and linear up to 1,000 U/ml TNF (Fig. 3 A) . To determine the kinetics of ICAM-1 expression, confluent ASM cells were stimulated with 100 U/ml of TNF-oe and changes in surface expression of ICAM-1 were determined between 0 and 48 h by flow cytometry. ICAM-1 expression was detectable by 4 h and maximal at 36 h (Fig. 3 B) .
Flow cytometry was also used to compare the effect of several other inflammatory mediators on ICAM-1 and VCAM-1 expression on ASM in vitro. Treatment with IL-1, LPS, and IFN-y for 24 h increased ICAM-1 expression, whereas VCAM-1 expression was most notably increased by IL-1 (Fig. 2) .
Adhesion Molecule Expression on ASM In Viva We extended the in vitro findings using an in vivo model of human bronchial tissue transplanted onto the flank of SCID mice (22) . [3SS]methionine-labeled protein from resting and TNF-ol-stimulated (100 U/ml) ASM was precipitated with mAbs as indicated and resolved on a 6% SDS-PAGE gel.
Immunocytochemistry of frozen sections of the bronchial xenograft (Fig. 4) demonstrated that minimal amounts of ICAM-1 and VCAM-1 were expressed on the ASM cells as identified by staining for smooth muscle actin (Fig. 4 , C and F) in untreated grafts (Fig. 4, A Fl uorescence i ntensi ty marked upregulation of ICAM-1 after 6 h (Fig. 4 D) and ICAM-1 and VCAM-1 after 18 h (Fig. 4 , G and H) on the submucosal smooth muscle tissue. In addition, there was marked expression of CD44 on both the ASM and the epithelium in both the TNF-c~-treated (Fig. 4/) and untreated (data not shown) xenografts. In addition, the expected increases in endothelial expression of ICAM-1 and VCAM-1 in response to TNF-ot stimulation were seen (Fig. 4, D, G , and H). Activated T Lymphocytes Adhere to ASM. To examine the capacity of T cells to adhere to ASM, we performed a quantitative adhesion assay. Between 5 and 10% of unstimulated T cells bound to resting ASM cells (Fig. 5) . In contrast, up to 30% of activated T cells bound to untreated ASM cells. Treatment of the ASM cells with TNF-ot for 24 h did not significantly increase adhesion of resting T cells, but enhanced adhesion of activated T cells up to 50%. This indicates that activation of T lymphocytes is required for their adhesion to ASM cells. Although upregulated expression of cell adhesion receptors by the ASM cells was not sufficient to mediate resting T lymphocyte adhesion, it enhanced adhesion of activated T cells.
T Cell Adhesion to ASM Is Mediated by Lymphocyte Integrins and CD44.
The role of specific adhesion receptors in mediating lymphocyte-ASM binding was determined using blocking mAbs (Fig. 6) . We observed partial inhibition of binding to TNF-ot-stimulated ASM when activated T cells were pretreated with mAbs against LFA-1 (Fig. 6, A and  B) or when the TNF-ot-stimulated ASM cells were pretreated with an antibody to ICAM-1 (Fig. 6 A) . When used alone, antibodies specific for VLA-4 (Fig. 6, A and B) or one of its ligands, VCAM-1 (Fig. 6 A) , had little inhibitory effect on adhesion of activated T cells to stimulated ASM. However, mAbs against LFA-1 and VLA-4 used together, or ICAM-1 and VCAM-1 in combination, inhibited binding
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Unstim. Figure 6 . T cell adhesion to ASM is mediated by LFA-1, VLA-4, and CD44. Activated T cells were pretreated with mAbs specific as indicated. ASM was stimulated with TNF-cz (1,000 U/ml) for 24 h; cells were also pretreated with mAbs specific for ICAM-1 and VCAM-1 where indicated. Percent adhesion was quantitated as described in Materials and Methods. Data from two (total n = 5) different experiments (A and B) are shown.
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to a greater extent than anti-LFA-1 or anti-ICAM-1 alone. Adhesion of activated T cells to resting ASM, although less than adhesion to TNF-c~-treated ASM, was inhibited proportionally to the same extent by these antibodies (data not shown).
Since we observed significant adhesion even in the presence of these combinations of mAbs, we investigated the potential role for a third adhesion pathway mediated by CD44-HA interactions. Pretreatment of T cells with a mAb specific for the HA binding site of CD44 (5F12) did not cause a decrease in activated T lymphocyte adhesion to TNF-ot-stimulated ASM (Fig. 6 B) . Pretreatment of the ASM monolayer with hyaluronidase also failed to decrease adhesion of activated T cells (data not shown). However, the combination of mAbs against LFA-1, VLA-4, and CD44 acted synergistically, reducing the binding of activated T cells to the level observed for resting T cells (Fig. 6 B) . LFA-1/VLA-4-independent adhesion was also sensitive to hyaluronidase treatment (data not shown). These data indicate that CD44 also plays a role in mediating T cell adhesion to ASM and accounts for the integrin-independent adhesion. Pretreatment of activated T cells with mAbs against L-selectin or against an epitope of CD44 not involved in HA binding (Hermes III) had no effect on adhesion (data not shown).
CD44 Is Sufficient to Mediate T Cell Adhesion to ASM. We 811
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observed that mAb against CD44 decreased T cell adhesion only in the absence ofintegrin-mediated adhesion. We therefore determined whether CD44 was sufficient to mediate adhesion or whether it was dependent on LFA-1 and/or VLA-4. For this purpose, we exploited the fact that murine LFA-1 does not bind to human ICAM-1 (24), whereas CD44-mediated binding is not species specific (25) . AKR1.G10 is a murine lymphoma line that expresses LFA-1, but not VLA-4 or CD44. This line does not bind appreciably to HA unless transfected with CD44 (21) . As expected, we also found that the LFA-1 expressed by this murine line could not mediate binding to human ASM cells. Thus, by comparing adhesion of the CD44-AKR1.G10 cells and AKR1.G10 transfected with murine CD44, we could test for integrin-independent, CD44-mediated adhesion. Staining with fluorescein-labeled Hermes III or HA indicated that the AKR1.G10 transfectants expressed similar levels of active CD44 compared with activated T lymphocytes (data not shown). AKR1.G10 cells transfected with vector alone did not bind significantly to human ASM, whereas cells transfected with murine CD44 demonstrated •50% binding (Fig. 7) . This interaction was specific, as it was inhibited by the mAb KM201 that blocks the HA binding site of murine CD44 (Fig. 7) as well as by soluble HA (data not shown). Furthermore, adhesion was reversible by digestion with hyaluronidase (Fig. 7) . These studies indicate that CD44 is sufficient to mediate T cell adhesion to ASM under certain conditions.
T Cell Adhesion Induces ASM DNA Synthesis. Smooth muscle cell hypertrophy and hyperplasia are hallmarks of asthma (26), however, the mechanisms that induce this response in ASM cells remain unknown. We studied the effect of T lymphocyte adherence on DNA synthesis in ASM as measured by uptake of BrdU (27) . We chose to use BrdU incorporation as a measure of DNA synthesis since this technique can distinguish DNA synthesis in individual cells. This method also allowed us to characterize the relationship be- tween adherent T cells to ASM cells that had entered the cell cycle. Using fluorescence microscopy, we observed that irradiated activated T cells adhered and induced a significant increase in the number of ASM cells incorporating BrdU, compared with no effect in ASM cells cocultured with resting T cells (Fig. 8, A and B vs. C and D) . Immunohistochemical analysis with an antibody against BrdU revealed fluorescence in less than 0.3 _+ 0.2% of ASM maintained in serum-free media compared with 30 + 2.4% of ASM treated with 10% FCS, a potent ASM mitogen (27) (Fig. 9) . BrdU incorporation was detected in 8.8 _+ 1.1% of growth-arrested ASM cocuhured with activated T lymphocytes, whereas neither unstimulated T cells nor the conditioned media from activated T cells (data not shown) induced DNA synthesis. In addition, the supernatant from ASM-T cell cocultures did not induce DNA synthesis in ASM (data not shown). Similar results were obtained when uptake of [3H]thymidine was measured (data not shown).
Discussion
Adhesion of lymphocytes to endothelium is necessary for their migration to areas of tissue injury. What are less well understood are the effector functions of these cells and the signals that contribute to ongoing immune stimulation once cells are recruited from the circulation. As lymphocytes migrate from the vascular space to the airway, it is likely that they interact with both extracellular matrix components and with the cellular components of the airway such as fibroblasts, dendritic cells and smooth muscle cells (28) . We show that ASM, both in vitro and in vivo, constitutively expresses high levels of CD44, and can be stimulated to express ICAM-1 and VCAM-1 in response to inflammatory mediators such as TNF-o~. It is noteworthy, therefore, that TNF-o~ levels are significantly increased in the bronchoalveolar lavage fluid from asthmatics compared with normal patients, with levels ranging from 600 to 10,000 pg/ml (29, 30) . Lymphocytes can interact with ASM cells in a regulated manner via specific adhesion receptors. Furthermore, the data illustrate that such interactions can stimulate DNA synthesis in ASM, which may be relevant to mechanisms that induce ASM cell hyperplasia.
The few studies that have examined the expression or function of adhesion molecules on smooth muscle cells have focused on vascular tissue. Li et al. (31) described an increase in VSM expression of VCAM-1 in response to IFN-3, and LPS, but not to IL-1 or TNF-o~. Couffinhal et al. (32) found that VSM treated with TNF-cr expressed functionally active ICAM-1 that mediated monocyte binding. In addition, Stemme et al. (33) demonstrated that ICAM-1 expression on VSM could be upregulated by IL-1, IFN-y, and LPS and was accompanied by a modest increase in T lymphoblast binding. In turn, binding could be partially inhibited by mAbs specific for ICAM-1, LFA-1, and CD29, implicating these receptors in the adhesion of T cells to VSM. However, the fact that blocking by these mAbs was incomplete suggests that additional adhesion pathways might be involved with adhesion to VSM as well.
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T Lymphocytes Adhere to Airway Smooth Muscle Cells tion by ASM from a representative experiment (n = 4) expressed as the ratio of positively staining nuclei/total nuclei _+ SEM was determined under the indicated conditions. *p <.001 compared with control.
We observed that adhesion of activated T lymphocytes to ASM was also only partially mediated by an LFA-1/ ICAM-1 interaction, and a role for VLA-4/VCAM-1 was only apparent in the absence of LFA-l-mediated adhesion. Similar findings suggesting the preferential use of LFA-1 over VLA-4 have also been reported for adhesion of activated T cells to endothelium (34) (35) (36) . We obtained no evidence to implicate L-selectin in adhesion of T cells to ASM. This is in contrast to recent work suggesting that L-selectin is important in T cell adhesion to resting and activated endothelium (34) .
One of the most important findings of this study was the definition of the integrin-independent adhesion of T cells to ASM as mediated by CD44. CD44, a glycoprotein with homology to core and link proteins, has been shown to serve as a homing molecule and as a receptor for HA (25, (37) (38) (39) . CD44 is expressed on a wide variety of cells and is present in an inactive form on resting lymphocytes. The physiologic stimuli that induce adhesion function of CD44 remain unknown. Engagement of other adhesion receptors may activate CD44, either by increasing expression and/or by increasing its affinity for HA. Studies by Lesley et al. (21, 40) indicate that cross-linking of CD44 by antibody can increase the affinity of CD44 for HA. In addition, there is evidence that T cell adhesion to endothelium is accompanied by the clustering of CD44 molecules on the surface of the lymphocyte oriented toward the endothelium (41) . This receptor clustering may lead to intracellular signaling, effecting a further increase in adhesiveness of the integrin receptors such as LFA-1 (42) (43) (44) . Similar examples of cross talk between receptors leading to cellular activation and adhesion have become increasingly recognized (45) .
The expression of CD44 on ASM cells as well as on T lymphocytes, combined with the ability of hyaluronidase to disrupt the T cell-ASM interaction, suggests that T cell CD44 binds to ASM-associated HA and that HA possibly provides a bridge between these two CD44-positive populations. The demonstration that CD44 can act as a primary mediator of lymphocyte adhesion to smooth muscle ceils underscores the potential importance of substrates such as hyaluronate in leukocyte trafficking, particularly in the context of inflammation. These results are consistent with our previous studies that indicated that CD44 expression is required for the generation of an optimal contact allergic response (46) .
There are a number of potentially important implications for lymphocyte-ASM cell interactions in the pathogenesis of asthma. For example, smooth muscle cells are not classically considered antigen presenting cells. Several investigators have demonstrated, however, that VSM can express MHC class II antigens in response to IFN-3, stimulation (47, 48) . We have found that MHC class II expression by ASM cells also is induced by IFN-3' (our unpublished observation). It is therefore possible that class II-expressing smooth muscle cells could serve an antigen presenting cells for preactivated T cells in the asthmatic airway.
Another role of this interaction may be in regulating ASM cell growth. We have demonstrated the ability of activated T lymphocytes to induce DNA synthesis in growth-arrested ASM. In addition, we found that maximal BrdU incorporation and uptake of [3H]thymidine induced by T cell adhesion to ASM coincided with the time necessary for serumstimulated ASM cells to cycle through S phase as determined by propidium iodide staining (data not shown). If T cell induced BrdU incorporation in ASM cells was due to DNA injury and repair, then we would not have expected such agreement in the time courses between these techniques. Whether this phenomenon occurs via direct cell-cell contact and/or local production of mediators needs to be determined. However, the ability of T lymphocyte adhesion to induce ASM proliferation in vitro suggests that this interaction may contribute to the airway remodeling that occurs in these patients.
In summary, this study has raised the possibility that the airway smooth muscle cell may be an important participant in the airway inflammatory response. ASM-lymphocyte interactions may have effects on both lymphocyte activation and function as well as on ASM cell growth and reactivity. 
